273 related articles for article (PubMed ID: 15495024)
1. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2004 Oct; (4):CD001964. PubMed ID: 15495024
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues JJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD001964. PubMed ID: 22258947
[TBL] [Abstract][Full Text] [Related]
3. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2003; (4):CD001964. PubMed ID: 14583942
[TBL] [Abstract][Full Text] [Related]
4. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer.
McCulloch P; Niita ME; Kazi H; Gama-Rodrigues JJ
Br J Surg; 2005 Jan; 92(1):5-13. PubMed ID: 15635680
[TBL] [Abstract][Full Text] [Related]
5. Extent of lymph node dissection for adenocarcinoma of the stomach.
Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: Current status of lymph node dissection.
Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
8. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
9. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Calvo F
Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592
[TBL] [Abstract][Full Text] [Related]
10. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
11. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M;
Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514
[TBL] [Abstract][Full Text] [Related]
12. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
Yildirim E; Celen O; Berberoglu U
J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
[TBL] [Abstract][Full Text] [Related]
13. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
14. Mortality and Morbidity and Disease Free Survival after D1 and D2 Gastrectomy for Stomach Adenocarcinomas.
Talaiezadeh AH; Asgari M; Zargar MA
Asian Pac J Cancer Prev; 2015; 16(13):5253-6. PubMed ID: 26225661
[TBL] [Abstract][Full Text] [Related]
15. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
19. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.
Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373
[TBL] [Abstract][Full Text] [Related]
20. Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection?
Zilberstein B; Mucerino DR; Yagi OK; Ribeiro-Junior U; Lopasso FP; Bresciani C; Jacob CE; Coimbra BG; Cecconello I
Arq Bras Cir Dig; 2012; 25(3):161-4. PubMed ID: 23411804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
